The PANSS should be rescaled.
作者信息
Leucht Stefan, Kissling Werner, Davis John M
机构信息
Klinik für Psychiatrie und Psychotherapie der TU-München, Klinikum rechts der Isar, Ismaningerstr. 22, 81675 München, Germany.
出版信息
Schizophr Bull. 2010 May;36(3):461-2. doi: 10.1093/schbul/sbq016. Epub 2010 Mar 31.
Abstract
摘要
相似文献
1
The PANSS should be rescaled.
Schizophr Bull. 2010 May;36(3):461-2. doi: 10.1093/schbul/sbq016. Epub 2010 Mar 31.
2
Should the PANSS be rescaled?
Schizophr Bull. 2010 May;36(3):455-60. doi: 10.1093/schbul/sbp124. Epub 2009 Nov 4.
3
Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode.
Schizophr Res. 2007 Sep;95(1-3):169-73. doi: 10.1016/j.schres.2007.05.035. Epub 2007 Jul 13.
4
Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
Acta Psychiatr Scand Suppl. 2009(438):7-14. doi: 10.1111/j.1600-0447.2008.01308.x.
5
The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability.
Acta Psychiatr Scand. 1992 Dec;86(6):463-8. doi: 10.1111/j.1600-0447.1992.tb03298.x.
6
7
Association of Positive and Negative Syndrome Scale short forms with global functioning and quality of life.
Acta Psychiatr Scand. 2016 Dec;134(6):563-565. doi: 10.1111/acps.12659. Epub 2016 Oct 24.
8
Item response analysis of the Positive and Negative Syndrome Scale.
BMC Psychiatry. 2007 Nov 15;7:66. doi: 10.1186/1471-244X-7-66.
9
Validation of the 16-item Negative Symptom Assessment.
J Psychiatr Res. 1993 Jul-Sep;27(3):253-8. doi: 10.1016/0022-3956(93)90036-2.
10
Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.
J Clin Psychiatry. 2001;62 Suppl 2:28-34.
引用本文的文献
1
Methods to address functional unblinding of raters in CNS trials.
Transl Psychiatry. 2025 Feb 7;15(1):47. doi: 10.1038/s41398-025-03262-1.
2
Network integration and segregation changes in schizophrenia: impact of electroconvulsive therapy.
BMC Psychiatry. 2024 Nov 30;24(1):862. doi: 10.1186/s12888-024-06331-9.
3
How to assess response.
Eur Arch Psychiatry Clin Neurosci. 2025 Aug;275(5):1531-1532. doi: 10.1007/s00406-024-01834-8. Epub 2024 Jun 5.
4
Effects of electroconvulsive therapy on functional brain networks in patients with schizophrenia.
BMC Psychiatry. 2024 Jan 8;24(1):29. doi: 10.1186/s12888-023-05408-1.
5
Longitudinal multi-omics alterations response to 8-week risperidone monotherapy: Evidence linking cortical thickness, transcriptomics and epigenetics.
Front Psychiatry. 2023 Mar 2;14:1127353. doi: 10.3389/fpsyt.2023.1127353. eCollection 2023.
6
Efficacy and safety of cariprazine augmentation in patients treated with clozapine: a pilot study.
Ther Adv Psychopharmacol. 2022 Nov 21;12:20451253221132087. doi: 10.1177/20451253221132087. eCollection 2022.
7
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial.
Curr Neuropharmacol. 2023;21(2):424-436. doi: 10.2174/1570159X21666221118164612.
8
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study.
BMJ Open. 2022 Nov 21;12(11):e062570. doi: 10.1136/bmjopen-2022-062570.
9
Deficit Symptomatology of Schizophrenia Is Associated with Attenuated Taste Identification: Findings from a Cross-Sectional Study.
Brain Sci. 2022 Nov 9;12(11):1520. doi: 10.3390/brainsci12111520.
10
Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration.
Psychiatr Res Clin Pract. 2020 Nov 6;3(1):38-45. doi: 10.1176/appi.prcp.20200003. eCollection 2021 Spring.
本文引用的文献
1
Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
Acta Psychiatr Scand Suppl. 2009(438):7-14. doi: 10.1111/j.1600-0447.2008.01308.x.
2
Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs.
Neuropsychopharmacology. 2007 Sep;32(9):1903-10. doi: 10.1038/sj.npp.1301325. Epub 2007 Feb 7.
3
Remission in schizophrenia: proposed criteria and rationale for consensus.
Am J Psychiatry. 2005 Mar;162(3):441-9. doi: 10.1176/appi.ajp.162.3.441.
4
A rating scale for depression.
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56.
5
The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
J Clin Psychopharmacol. 1994 Oct;14(5):344-6.
6
The positive and negative syndrome scale (PANSS) for schizophrenia.
Schizophr Bull. 1987;13(2):261-76. doi: 10.1093/schbul/13.2.261.
7
A new depression scale designed to be sensitive to change.
Br J Psychiatry. 1979 Apr;134:382-9. doi: 10.1192/bjp.134.4.382.
Zotero 插件